| INTRODUCTION
Immunoglobulin free light chains (FLCs) are normally produced in slight excess by B-Cells in order to provide correct assembly of intact immunoglobulins (Igs). Nevertheless, only 60% of FLCs are correctly assembled into newly synthesized Igs, whereas the rest are released in the blood circulation giving rise to the serum polyclonal FLC pool.
The excess is cleared by catabolic action of enzymes in the proximal tubules of the kidney. 1 In physiological conditions, approximately 500 mg of serum FLCs (sFLC) is produced on a daily basis, with a half-life ranging from 2 to 6 hours. Consequently, as sFLC concentrations are dependent on both their production and renal clearance, any over production as well as renal impairment may contribute to a shift in the normal sFLC concentration, giving rise to abnormal sFLC concentrations. clinical practice for diagnosis, monitoring and follow-up of monoclonal gammopathies. [3] [4] [5] [6] [7] [8] [9] [10] The International Myeloma Working Group has recently included sFLC detection in clinical settings other than monoclonal gammopathies and plasma cell dyscrasias. 9 The FLC ratio ≥100, from SLiM CRAB criteria (S: 60% or greater clonal plasma cells; Li:
Involved/Uninvolved Light chains ≥100; M: MRI 1 or more focal lesion; C: calcium elevation; R: renal insufficiency; A: anemia; B:
bone lesions), is a predictor of imminent progression of smouldering multiple myeloma (SMM) to overt multiple myeloma (MM) and that such patients should be regarded as having MM requiring therapy.
11
Serum FLC are involved in a variety of pathological conditions related to natural and acquired immunity; 12 therefore, it is plausible that sFLC testing may have clinical indications not yet fully understood. 13 As a pioneer of the field, the Freelite assay shows poor postdilution linearity and relative imprecision, as well as increased probability of yielding false negative results due to antigen excess in patients with extremely high FLC concentration. 14, 15 When using the Freelite assay, laboratories may be faced with several analytical problems including lot-to-lot variability of reagents, antigen excess, unrecognizable epitopes, excessive polymerization [16] [17] [18] and different results obtained on different platforms as reports of the specific UK-NEQAS.
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In order to overcome some of these problems, the N Latex assay by Siemens based on monoclonal antibodies was recently introduced to the worldwide market. 
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The core of the problem is that both methods rely on different cal- This issue was noted in a recently published article, in which the above mentioned sFLC assays were compared in a multicenter study.
The authors conclude that both methods perform very differently, and they advise the use of the same method in routine testing, especially for patient monitoring. 21, 25 Due to these discrepancies and confusion generated by conflicting reports, we considered it necessary to perform an accurate analysis of both methods. Our study aims to verify differences and compatibilities between the two methods on two different laboratory platforms. Recently, the IMWG guidelines have highlighted the importance of using an appropriate test for the correct interpretation of the κ/λ ratio in defining different degrees of SMM.
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| MATERIALS AND METHODS
This multicenter study was performed using samples obtained from two separate diagnostic centers in Italy (National Cancer Institute "Regina Elena", Foundation "A. Gemelli" Catholic University of the Sacred Heart, Rome).
Random serum samples submitted for routine analysis from a total of 300 patients, 139 Female (mean age 66±12 . This operation was done after controls were tested on each relative platform, and results were within the expected range. Inter-assay imprecision was evaluated with commercial normal and pathological quality controls, on a daily basis. The study was assessed, during 20 days, using different reagent lots and calibrations. 27 Method comparison was led according to CLSI EP-09 A3 guideline. 
| Statistical analysis
The results were analyzed by Bland-Altman plots, in order to evaluate comparability of the two methods and to estimate the differences.
We decided to avoid log-transformed data in order to have a more dynamic vision of results as a whole, so as to gain knowledge of dispersion. We compared the Freelite vs N Latex assay using PassingBablok regression analysis with determination of the intercept, slope and coefficient of correlation. The scatter of difference was showed on Bland-Altman Plots. Clinical concordance was assessed by creating a 3 by 3 contingency table accordingly to whether the patients would be classified as having abnormal or normal κ/λ ratio (normal range:
0.26-1.65). 9 The level of agreement was evaluated through Cohen's kappa statistics. Perfect agreement was set for kappa value ≥0.8; good agreement ranging from 0.6 to 0.8 and moderate agreement between 0.4 and 0.6.
All statistical analysis was performed using XLSTAT (Addinsoft SARL, New York, NY, USA). P<.05 was considered statistically significant.
| RESULTS
For the comparison study, we used 345 samples out of 350, because five of them were outliers and therefore excluded from the data set. Results of κ FLC for some samples gave discrepancies between the two assays as indicated in Table 1 . Results of λ FLC for some samples gave discordant results between the two assays as shown in Table 1 . Table 2 ).
| DISCUSSION
As serum FLC analysis is being more frequently requested in clinics, it is of equal importance to validate the analytical systems for diagnosing and monitoring disease states, but also to verify whether the two analytical system available show interchangeable results. This is of crucial importance for those patients requiring monitoring and follow-up of MCs.
The consequence of the variability of the measurand is that unless a FLC immunoassay can recognize all molecular forms and conformations of the FLC with equimolar reactivity, the different forms will not produce the same FLC result for all patients.
The absence of a reference material, as well as the great difference found between the assays, strongly calls for the need of an international available standard calibrator, in order to standardize the two methods.
In terms of interchangeability, our study demonstrates that the two analyzers do not allow results to be transferred from one method to the other, as values are not totally overlapping and do not reach the perfect agreement.
As we do not know the precise value of the data (due to the lack of an international standard), we cannot define accuracy and thus, we cannot state that this method is more accurate than the N Latex assay.
Data display highest bias found between the assays. This may be due to the difference in methods used by the analyzers. In previous comparison studies, all samples were tested for measurement with Freelite and N Latex assays only on Siemens Dade Behring BN II Nephelometer. [29] [30] [31] In this study, we compared the results obtained with the recommended manufacturer's instrumentation to assess if there was a better correlation between data. Our study therefore points to the importance of reaching an international standard, in order to offer interchangeable results among laboratories and instruments.
Although the two methods have different reference ranges for κ/λ ratio, the FLC range reported in Table 2 is justified by its presence in IMWG guidelines as global diagnostic reference range in clinical management. 9, 11, 26, 32 At the same time, MCs are also highly variable, so one assay method may be more accurate to determine one type of component, whereas another may be less. As a result of the unpredictable values, showing there is no longer the great lot-to-lot reagent variability for their polyclonal-based assay. 19 Siemens N Latex assay uses monoclonal antibodies and has published on reagent lot-to-lot variation. 20 This was done in order to ensure all analytical issues are accurately evaluated when considering results obtained with this kind of assay, so they can be progressively overcome by the assay manufacturer. Even if the measurement range of FLCs is from 1-100 000 mg/L, there is still a possibility of having an antigen excess phenomenon, with a concurring risk of missing diagnosis for a subset of diseases which actually require immediate therapeutic schemes.
Alternatively, mass spectrometry can readily identify a monoclonal FLC from the polyclonal background and identify the isotype of the light chain by top-down mass spectrometry eliminating the need for reference ranges to determine if a monoclonal FLC is present. 33 The development of this assay requires a collaboration between clinics and laboratory services to monitor the entire clinical status of each individual. While there is still a lack of studies concerning biological inter-and intra-individual variability of FLC in serum, it is of increasing urgency to accomplish these analytical goals. 
